Sign In
Buy SNY
$44.38
+2.01 (+4.74%)
At Close: Jun 04, 2026
Sanofi (SNY) to Reduce Lantus Insulin Price by Up to 78%
11:30am, Friday, 17'th Mar 2023
Sanofi (SNY) plans to lower the prices of its most widely used insulin Lantus by upto 78% in the United States, effective January 2024.
Sanofi becomes latest to cut insulin prices, joins Novo Nordisk, Eli Lilly
10:25am, Friday, 17'th Mar 2023
Yahoo Finance's Anjalee Khemlani joins the Live show to report that Sanofi has become the latest major drug company to slash insulin prices, capping the cost at $35.
Sanofi Cuts Insulin Prices Up To 78%—Following Eli Lilly And Novo Nordisk
05:45pm, Thursday, 16'th Mar 2023
The French company will cap the monthly cost of insulin at $35, after Novo Nordisk and Eli Lilly also announced major price cuts earlier this month.
Sanofi to slash U.S. insulin prices in 2024 after similar cuts by Eli Lilly and Novo Nordisk
04:45pm, Thursday, 16'th Mar 2023
The French drugmaker is the last major insulin manufacturer to try to head off government efforts to cap monthly costs by announcing its own steep price cuts.
Sanofi to cap price of Lantus insulin at $35
04:24pm, Thursday, 16'th Mar 2023
Sanofi SNY FR:SAN said Thursday that it will cut the U.S. list price of Lantus by 78%, and it will also cap out-of-pocket costs at $35 for the same insulin for people with commercial health insurance,
2 Top Biotech Stocks to Buy Right Now
09:30am, Wednesday, 15'th Mar 2023
Sanofi and Amgen both have the two most important characteristics that investors should seek from pharmaceutical companies. Sanofi stock is where growth and value intersect.
This biopharma stock jumped over 250% on Monday: what happened?
08:22pm, Monday, 13'th Mar 2023
Shares of Provention Bio Inc (NASDAQ: PRVB) more than tripled on Monday after Sanofi S.A. (EPA: SAN) confirmed plans of buying the biopharmaceutical company that focused on autoimmune diseases.
Week Ahead: Banking Crisis, Inflation Reports, and Big Pharma Acquisitions
05:34pm, Monday, 13'th Mar 2023
Last week ended on a hectic note
Provention Bio shares soar after Sanofi agrees to buy company in $2.9B cash deal
10:15am, Monday, 13'th Mar 2023
French drugmaker Sanofi has announced an agreement to acquire US-based biopharmaceutical company Provention Bio Inc (NASDAQ:PRVB), which focuses on autoimmune diseases, for $25 per share in cash, or
Pfizer Officially Nabs Seagen For $43 Billion; Provention Soars On Sanofi Deal
09:17am, Monday, 13'th Mar 2023
Pfizer will buy Seagen for roughly $43 billion, and Sanofi will buy Provention for $2.9 billion. SGEN stock and PRVB stock soared.
Sanofi To Buy Provention Bio In $2.9 Billion Deal (SNY) (PRVB)
06:43am, Monday, 13'th Mar 2023
Sanofi (NASDAQ: SNY) announced it is buying Provention Bio (NASDAQ: PRVB) as part of a $2.9 billion deal. These are the details.
Sanofi to buy Provention Bio in deal worth $2.9 billion
02:49am, Monday, 13'th Mar 2023
French pharmaceutical group Sanofi said Monday that it will buy Provention Bio, Inc., a U.S.-based biopharmaceutical company focused on autoimmune diseases, for $25 per share in cash, in a deal with a
5 Large Drug Stocks to Watch as Sector Picks Up in 2023
09:11am, Thursday, 09'th Mar 2023
Drug/biotech companies are likely to see significant advances in innovation in 2023. In the Large-Cap Pharmaceuticals industry, J&J (JNJ), Novo Nordisk (NVO), AstraZeneca (AZN), Novartis (NVS), and Sa
International Wide-Moat Stocks On Sale - The March 2023 Heat Map
12:56am, Wednesday, 08'th Mar 2023
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
7 Blue-Chip Stocks to Buy for Quality-Focused Investors
04:17pm, Monday, 06'th Mar 2023
When the game's on the line, sometimes you need to call up your most experienced players, which segues into this discussion of blue-chip stocks to buy. Any sports fan realizes that age comes for every
